tirzepatide pharmaceutical company Injection | Starts at $249/mo Major manufacturing investment to support

Tirzepatide is a dual GLP-1 and GIP receptor agonist that can support weight loss, but people with hypothyroidism need specific information about interactions, thyroid function monitoring, and personalized dosing strategies

15mg & 30mg vials

Biocare GLP-1s Drink

Switching from semaglutide to tirzepatide requires understanding how dual-action GLP-1/GIP therapy differs from single-pathway treatment

So far, however, it has been injectables leading the way to approval.

Discover how combining HRT and GLP-1 therapy helps women in perimenopause and menopause achieve better weight loss, improved metabolic health, and long-term wellness